Kersbrook, United Kingdom

Stanley Michael Roberts


Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Kersbrook, GB (2007)
  • Kirsbrook, GB (2007 - 2010)
  • Manchester, GB (2013)

Company Filing History:


Years Active: 2007-2013

where 'Filed Patents' based on already Granted Patents

4 patents (USPTO):

Title: The Innovative Contributions of Stanley Michael Roberts

Introduction

Stanley Michael Roberts is a notable inventor based in Kersbrook, GB. He has made significant contributions to the field of pharmaceutical compositions, holding a total of 4 patents. His work focuses on developing compounds that have therapeutic applications, showcasing his commitment to advancing medical science.

Latest Patents

Roberts' latest patents include innovative pharmaceutical compositions. One of his inventions relates to compounds of formula I or II, where R represents various groups that may be substituted or unsubstituted. These compounds are designed for use in therapeutic, diagnostic, and research methods. Another patent involves a compound comprising a cyclopentanone, cyclopentenone, cyclohexanone, or cyclohexenone group, which aims to improve solubility and therapeutic index compared to existing derivatives.

Career Highlights

Throughout his career, Stanley Michael Roberts has worked with several prominent companies, including Charterhouse Therapeutics Ltd. and Crawford Healthcare Holdings Limited. His experience in these organizations has allowed him to contribute to the development of innovative pharmaceutical solutions.

Collaborations

Roberts has collaborated with notable professionals in his field, including Maria Gabriella Santoro and Vasudev Jadhav. These partnerships have further enhanced his research and development efforts.

Conclusion

Stanley Michael Roberts is a distinguished inventor whose work in pharmaceutical compositions has the potential to impact therapeutic practices significantly. His innovative spirit and dedication to research continue to drive advancements in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…